Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-17 Sale | 2024-04-19 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 6,853 | $22.37 | $153,327 | 97,227 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $22.38 | $89,522 | 6,301 (Direct) | View |
| 2024-04-16 Sale | 2024-04-18 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | 10,000 | $24.7 | $246,971 | 363,381 (Direct) | View |
| 2024-04-10 Sale | 2024-04-12 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 7,500 | $26.85 | $201,392 | 45,723 (Direct) | View |
| 2024-04-09 Sale | 2024-04-11 6:00 pm | Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director | 11,882 | $28.15 | $334,478 | 1,799,232 (Indirect) | View |
| 2024-04-01 Sale | 2024-04-03 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | 10,000 | $30 | $300,033 | 373,381 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 3,325 | $31.97 | $106,317 | 26,966 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER | 5,300 | $29.19 | $154,697 | 79,400 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 12,495 | $31.23 | $390,208 | 17,728 (Direct) | View |
| 2024-03-28 Sale | 2024-04-01 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 9,000 | $29.5 | $265,500 | 92,761 (Direct) | View |
| 2024-03-27 Sale | 2024-03-28 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 11,068 | $27.97 | $309,519 | 30,291 (Direct) | View |
| 2024-03-25 Sale | 2024-03-27 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 3,432 | $28.01 | $96,119 | 41,359 (Direct) | View |
| 2024-03-19 Sale | 2024-03-20 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER | 5,300 | $26.08 | $138,243 | 84,700 (Direct) | View |
| 2024-03-18 Sale | 2024-03-20 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 7,000 | $25.87 | $181,057 | 105,797 (Direct) | View |
| 2024-03-18 Sale | 2024-03-20 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 35,057 | $25.9 | $908,046 | 147,580 (Direct) | View |
| 2024-03-12 Sale | 2024-03-14 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 4,067 | $25.03 | $101,815 | 106,502 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 25,933 | $25.03 | $649,205 | 203,193 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 8,975 | $24.5 | $219,888 | 120,085 (Direct) | View |
| 2024-02-23 Sale | 2024-02-27 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 511 | $19.5 | $9,965 | 6,265 (Direct) | View |
| 2024-02-20 Sale | 2024-02-22 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 3,489 | $20.23 | $70,575 | 14,812 (Direct) | View |
| 2024-02-05 Sale | 2024-02-07 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $17.45 | $80,249 | 111,539 (Direct) | View |
| 2024-01-17 Sale | 2024-01-19 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $19.5 | $78,000 | 9,278 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $19.16 | $88,116 | 116,139 (Direct) | View |
| 2023-12-27 Sale | 2023-12-29 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 125 | $24.5 | $3,063 | 129,060 (Direct) | View |
| 2023-12-20 Sale | 2023-12-22 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $19.5 | $78,000 | 22,301 (Direct) | View |
| 2023-12-13 Sale | 2023-12-15 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 12,000 | $19.5 | $234,000 | 59,248 (Direct) | View |
| 2023-12-05 Sale | 2023-12-07 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $16.3 | $74,996 | 120,739 (Direct) | View |
| 2023-12-06 Sale | 2023-12-07 6:00 pm | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 10,283 | $16.11 | $165,628 | 153,892 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-17 Exercise | 2024-04-19 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 6,853 | $0 | 97,227 (Direct) | View |
| 2024-04-17 Exercise | 2024-04-19 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 6,853 | $2.14 | 97,227 (Direct) | View |
| 2024-04-17 Exercise | 2024-04-19 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $1.74 | 6,301 (Direct) | View |
| 2024-04-17 Exercise | 2024-04-19 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $0 | 6,301 (Direct) | View |
| 2024-04-16 Exercise | 2024-04-18 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | 10,000 | $0 | 363,381 (Direct) | View |
| 2024-04-16 Exercise | 2024-04-18 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | 10,000 | $2.14 | 363,381 (Direct) | View |
| 2024-04-10 Exercise | 2024-04-12 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 7,500 | $0 | 45,723 (Direct) | View |
| 2024-04-10 Exercise | 2024-04-12 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 7,500 | $2.14 | 45,723 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | 10,000 | $0 | 373,381 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | 10,000 | $2.14 | 373,381 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A 2031-12-13 | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 3,325 | $0 | 26,966 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 3,325 | $10.61 | 26,966 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A 2032-03-20 | Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER | 5,300 | $0 | 79,400 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER | 5,300 | $14.59 | 79,400 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 12,495 | $0 | 17,728 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 12,495 | $2.14 | 17,728 (Direct) | View |
| 2024-03-28 Exercise | 2024-04-01 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 9,000 | $0 | 92,761 (Direct) | View |
| 2024-03-28 Exercise | 2024-04-01 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 9,000 | $2.14 | 92,761 (Direct) | View |
| 2024-03-27 Exercise | 2024-03-28 6:00 pm | N/A 2031-12-13 | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 11,068 | $0 | 30,291 (Direct) | View |
| 2024-03-27 Exercise | 2024-03-28 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 11,068 | $10.61 | 30,291 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 6:00 pm | N/A 2031-12-13 | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 3,432 | $0 | 41,359 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 3,432 | $10.61 | 41,359 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-20 6:00 pm | N/A 2032-03-20 | Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER | 5,300 | $0 | 84,700 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-20 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER | 5,300 | $14.59 | 84,700 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $1.74 | 105,797 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 7,000 | $0 | 105,797 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 3,000 | $2.14 | 105,797 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 35,057 | $0 | 147,580 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 20,557 | $2.14 | 147,580 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 14,500 | $10.61 | 147,580 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 4,067 | $0 | 106,502 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 4,067 | $2.14 | 106,502 (Direct) | View |
| 2024-03-07 Exercise | 2024-03-11 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 25,933 | $0 | 203,193 (Direct) | View |
| 2024-03-07 Exercise | 2024-03-11 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 25,933 | $2.14 | 203,193 (Direct) | View |
| 2024-03-07 Exercise | 2024-03-11 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 8,975 | $0 | 120,085 (Direct) | View |
| 2024-03-07 Exercise | 2024-03-11 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 8,975 | $2.14 | 120,085 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 6:00 pm | N/A 2034-03-04 | Aerovate Therapeutics Inc. | AVTE | Dable Habib J Director | 1,531 | $16.37 | 1,531 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 511 | $1.74 | 6,265 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 511 | $0 | 6,265 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-22 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 3,489 | $1.74 | 14,812 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-22 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 3,489 | $0 | 14,812 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,400 | $1.74 | 111,539 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $0 | 111,539 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 3,200 | $2.14 | 111,539 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 6:00 pm | N/A 2034-01-28 | Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 6:00 pm | N/A 2034-01-21 | Aerovate Therapeutics Inc. | AVTE | Pigot Timothy CHIEF COMMERCIAL OFFICER | 66,586 | $0 | 67,877 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 6:00 pm | N/A 2034-01-21 | Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNOLOGY OFFICER | 66,586 | $0 | 66,586 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 6:00 pm | N/A 2034-01-21 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 66,586 | $0 | 66,586 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 6:00 pm | N/A 2034-01-21 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 66,586 | $0 | 66,586 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 6:00 pm | N/A 2034-01-21 | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 66,586 | $0 | 66,586 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 6:00 pm | N/A 2034-01-21 | Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS | 66,586 | $0 | 66,586 (Direct) | View |
| 2024-01-17 Exercise | 2024-01-19 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $1.74 | 9,278 (Direct) | View |
| 2024-01-17 Exercise | 2024-01-19 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $0 | 9,278 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,400 | $1.74 | 116,139 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $0 | 116,139 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 3,200 | $2.14 | 116,139 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 6:00 pm | N/A 2034-01-01 | Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director | 2,889 | $13.49 | 2,889 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 6:00 pm | N/A 2034-01-01 | Aerovate Therapeutics Inc. | AVTE | Dable Habib J Director | 2,964 | $13.49 | 2,964 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 6:00 pm | N/A 2034-01-01 | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 3,519 | $13.49 | 3,519 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 6:00 pm | N/A 2034-01-01 | Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director | 3,186 | $13.49 | 3,186 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 6:00 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 125 | $0 | 129,060 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 125 | $2.14 | 129,060 (Direct) | View |
| 2023-12-13 Exercise | 2023-12-22 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $1.74 | 22,301 (Direct) | View |
| 2023-12-20 Exercise | 2023-12-22 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 4,000 | $0 | 22,301 (Direct) | View |
| 2023-12-13 Exercise | 2023-12-15 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 12,000 | $1.74 | 59,248 (Direct) | View |
| 2023-12-13 Exercise | 2023-12-15 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER | 12,000 | $0 | 59,248 (Direct) | View |
| 2023-12-05 Exercise | 2023-12-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,400 | $1.74 | 120,739 (Direct) | View |
| 2023-12-05 Exercise | 2023-12-07 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $0 | 120,739 (Direct) | View |
| 2023-12-05 Exercise | 2023-12-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 3,200 | $2.14 | 120,739 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 2,411 | $1.74 | 153,892 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-07 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 10,283 | $0 | 153,892 (Direct) | View |
| 2023-12-06 Exercise | 2023-12-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS | 7,872 | $2.14 | 153,892 (Direct) | View |